Literature DB >> 23478020

Suppression of host p53 is critical for Plasmodium liver-stage infection.

Alexis Kaushansky1, Albert S Ye, Laura S Austin, Sebastian A Mikolajczak, Ashley M Vaughan, Nelly Camargo, Peter G Metzger, Alyse N Douglass, Gavin MacBeath, Stefan H I Kappe.   

Abstract

Plasmodium parasites infect the liver and replicate inside hepatocytes before they invade erythrocytes and trigger clinical malaria. Analysis of host signaling pathways affected by liver-stage infection could provide critical insights into host-pathogen interactions and reveal targets for intervention. Using protein lysate microarrays, we found that Plasmodium yoelii rodent malaria parasites perturb hepatocyte regulatory pathways involved in cell survival, proliferation, and autophagy. Notably, the prodeath protein p53 was substantially decreased in infected hepatocytes, suggesting that it could be targeted by the parasite to foster survival. Indeed, mice that express increased levels of p53 showed reduced liver-stage parasite burden, whereas p53 knockout mice suffered increased liver-stage burden. Furthermore, boosting p53 levels with the use of the small molecule Nutlin-3 dramatically reduced liver-stage burden in vitro and in vivo. We conclude that perturbation of the hepatocyte p53 pathway critically impacts parasite survival. Thus, host pathways might constitute potential targets for host-based antimalarial prophylaxis.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478020      PMCID: PMC3619000          DOI: 10.1016/j.celrep.2013.02.010

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  24 in total

1.  Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids.

Authors:  Angelika Sturm; Rogerio Amino; Claudia van de Sand; Tommy Regen; Silke Retzlaff; Annika Rennenberg; Andreas Krueger; Jörg-Matthias Pollok; Robert Menard; Volker T Heussler
Journal:  Science       Date:  2006-08-03       Impact factor: 47.728

2.  HGF/MET signalling protects Plasmodium-infected host cells from apoptosis.

Authors:  Patrícia Leirião; Sónia S Albuquerque; Simona Corso; Geert-Jan van Gemert; Robert W Sauerwein; Ana Rodriguez; Silvia Giordano; Maria M Mota
Journal:  Cell Microbiol       Date:  2005-04       Impact factor: 3.715

3.  Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

Authors:  Tongyuan Li; Ning Kon; Le Jiang; Minjia Tan; Thomas Ludwig; Yingming Zhao; Richard Baer; Wei Gu
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

4.  "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally.

Authors:  Isabel García-Cao; Marta García-Cao; Juan Martín-Caballero; Luis M Criado; Peter Klatt; Juana M Flores; Jean-Claude Weill; María A Blasco; Manuel Serrano
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

5.  The liver stage of Plasmodium berghei inhibits host cell apoptosis.

Authors:  Claudia van de Sand; Sebastian Horstmann; Anja Schmidt; Angelika Sturm; Stefanie Bolte; Andreas Krueger; Marc Lütgehetmann; Jörg-Matthias Pollok; Claude Libert; Volker T Heussler
Journal:  Mol Microbiol       Date:  2005-11       Impact factor: 3.501

6.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

7.  Hepatocyte growth factor and its receptor are required for malaria infection.

Authors:  Margarida Carrolo; Silvia Giordano; Laura Cabrita-Santos; Simona Corso; Ana M Vigário; Susana Silva; Patricia Leirião; Daniel Carapau; Rosario Armas-Portela; Paolo M Comoglio; Ana Rodriguez; Maria M Mota
Journal:  Nat Med       Date:  2003-10-12       Impact factor: 53.440

8.  Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53.

Authors:  Robert Eferl; Romeo Ricci; Lukas Kenner; Rainer Zenz; Jean-Pierre David; Martina Rath; Erwin F Wagner
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

9.  Tumor spectrum analysis in p53-mutant mice.

Authors:  T Jacks; L Remington; B O Williams; E M Schmitt; S Halachmi; R T Bronson; R A Weinberg
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

10.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

View more
  51 in total

Review 1.  Looking under the skin: the first steps in malarial infection and immunity.

Authors:  Robert Ménard; Joana Tavares; Ian Cockburn; Miles Markus; Fidel Zavala; Rogerio Amino
Journal:  Nat Rev Microbiol       Date:  2013-10       Impact factor: 60.633

2.  Host ER stress during malaria parasite infection.

Authors:  Alexis Kaushansky; Stefan H I Kappe
Journal:  EMBO Rep       Date:  2015-07-02       Impact factor: 8.807

3.  Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection.

Authors:  Elizabeth K K Glennon; Laura S Austin; Nadia Arang; Heather S Kain; Fred D Mast; Kamalakannan Vijayan; John D Aitchison; Stefan H I Kappe; Alexis Kaushansky
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

4.  Targeting liver stage malaria with metformin.

Authors:  Iset Medina Vera; Margarida T Grilo Ruivo; Leonardo F Lemos Rocha; Sofia Marques; Sangeeta N Bhatia; Maria M Mota; Liliana Mancio-Silva
Journal:  JCI Insight       Date:  2019-12-19

5.  Susceptibility to Plasmodium yoelii preerythrocytic infection in BALB/c substrains is determined at the point of hepatocyte invasion.

Authors:  Alexis Kaushansky; Laura S Austin; Sebastian A Mikolajczak; Fang Y Lo; Jessica L Miller; Alyse N Douglass; Nadia Arang; Ashley M Vaughan; Malcolm J Gardner; Stefan H I Kappe
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

6.  Susceptibility to Plasmodium liver stage infection is altered by hepatocyte polyploidy.

Authors:  Laura S Austin; Alexis Kaushansky; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2014-03-28       Impact factor: 3.715

Review 7.  Selection and refinement: the malaria parasite's infection and exploitation of host hepatocytes.

Authors:  Alexis Kaushansky; Stefan Hi Kappe
Journal:  Curr Opin Microbiol       Date:  2015-06-21       Impact factor: 7.934

Review 8.  Malaria Parasite Liver Infection and Exoerythrocytic Biology.

Authors:  Ashley M Vaughan; Stefan H I Kappe
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

9.  No association of the p53 codon 72 polymorphism with malaria in Ghanaian primiparae and Rwandan children.

Authors:  Prabhanjan P Gai; Stefanie Meese; George Bedu-Addo; Jean Bosco Gahutu; Frank P Mockenhaupt
Journal:  Am J Trop Med Hyg       Date:  2014-04-07       Impact factor: 2.345

10.  Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites.

Authors:  Alyse N Douglass; Heather S Kain; Marian Abdullahi; Nadia Arang; Laura S Austin; Sebastian A Mikolajczak; Zachary P Billman; Jen C C Hume; Sean C Murphy; Stefan H I Kappe; Alexis Kaushansky
Journal:  Mol Ther       Date:  2015-02-04       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.